Effect of beta blockers after coronary artery bypass in postinfarct patients: What can we learn from available literature?

Annals of Thoracic Surgery

Volumn 74, Issue 5, 2002, Pages 1727-1732

  Geraci, Stephen A ^a   Haan, Constance K ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF FLORIDA HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; TIMOLOL;

ACUTE HEART INFARCTION; BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL FEATURE; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DRESSLER SYNDROME; DRUG EFFICACY; HEART ARRHYTHMIA; HEART DISEASE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INCIDENCE; LONG TERM CARE; META ANALYSIS; MORTALITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PUBLICATION; REVIEW; SURVIVAL;

EID: 0036841413     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(02)03992-9     Document Type: Article

References (31)

1. Braunwald E, Jones R, Mark DB. Diagnosing and managing unstable angina. Circulation 1994;90:613-22.
2. Wang TJ, Stafford RS. National patterns and predictors of beta blocker use in patients with coronary artery disease. Arch Intern Med 1998;158:1901-6.
3. First International Study of Infarct Survival Collaborative Group. Randomized, trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1. Lancet 1986;2:57-66.
4. The MIAMI Trial Research Group, Metoprolol in acute myocardial infarction. Am J Cardiol 1985;57:1G-57G.
5. ACC/AHA guidelines for the management of patients with acute myocardial Infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1996;28:1328-428.
6. Herlitz J, Dellborg M, Karlson BW, Lindquist J, Wedel H. Long-term mortality after acute myocardial infarction in relation to prescribed dosages of a beta blocker at hospital discharge. Cardiovasc Drugs Ther 2001;14:589-95.
7. Selzman CH, Miller SA, Zimmerman MA, Harken AH. The case for beta adrenergic blockade as prophylaxis against perioperative cardiovascular morbidity and mortality. Arch Surg 2001;136:286-90.
8. Wallace A, Layug B, Tateo I, et al. Prophylactic atenolol reduces postoperative myocardial ischemia. Anesthesiology 1998;88:7-17.
9. Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 1996;335:1713-20.
10. Viskin S, Kitzis I, Lev E, et al. Treatment with beta adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice. J Am Coll Cardiol 1995;25:1327-32.
11. The MACB Study Group. Effect of metoprolol on death and cardiac events during a 2-year period after coronary artery bypass grafting. Eur Heart J 1995;16:1825-32.
12. Chen J, Radford MJ, Wang Y, Marciniak TA, Krumholz HM. Are β-blockers effective in elderly patients who undergo coronary revascularization after acute myocardial infarction? Arch Intern Med 2000;160:947-52.
13. The Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981;304:801-7.
14. β-blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. JAMA 1982;247:1707-13.
15. Hjalmarson A, Elmfeldt D, Herlitz J, et al. Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomized trial. Lancet 1981;2:823-27.
16. Barron HF, Viskin S, Lundstrom RJ, et al. Effect of beta adrenergic blocking agents on mortality rate in patients not revascularized after myocardial infarction: Data from a large HMO. Am Heart J 1997;134:608-13.
17. Hasdai D, Lerman A, Grill DE, Rihal CS, Holmes DR Jr. Medical therapy after successful percutaneous coronary revascularization. Ann Intern Med 1999;130:108-15.
18. Sharma SK, Kini A, Marmur JD, Fuster V. Cardioprotective effect of prior β-blocker therapy in reducing creatine kinase-MB elevation after coronary intervention. Circulation 2000;102:166-72.
19. Silber S, Krischke I, Prohaska M. Undertreatment in secondary prevention of patients with coronary heart disease after revascularization. Herz 2000;25:623-6.
20. Weightman WM, Gibbs NM, Sheminant MR, Witford EG, Mahon BD, Newman MA. Drug therapy before coronary artery surgery: Nitrates are independent predictors of mortality and beta adrenergic blockers predict survival. Anesth Analg 1999;88:286-91.
21. Geissler HJ, Davis KL, Laine GA, et al. Myocardial protection with high-dose β-blockade in acute myocardial ischemia. Eur J Cardiothorac Surg 2000;17:63-70.
22. Mehlhorn U, Saurer H, Kuhn-Regnier F, et al. Myocardial β-blockade as an alternative to cardioplegic arrest during coronary artery surgery. Cardiovasc Surg 1999;7:549-57.
23. Hirsch WS, Ledley GS, Kotler MN. Acute ischemic syndromes following coronary artery bypass graft surgery. Clin Cardiol 1998;21:625-32.
24. Sjoland H, Caidahl K, Lurje L, Hjalmarson A, Herlitz J. Metoprolol treatment for two years after coronary bypass grafting: Effects on exercise capacity and signs of myocardial ischemia. Br Heart J 1995;74:235-41.
25. Sarasin FP, Maschiangelo ML, Schaller MD, Heliot C, Mischler S, Gaspoz JM. Successful implementation of guidelines for encouraging the use of beta blockers in patients after acute myocardial infarction. Am J Med 1999;106:499-505.
26. Iliadis EA, Klein LW, Vandenberg BJ, et al. Clinical practice guidelines in unstable angina improve clinical outcomes by assuring early intensive medical treatment. J Am Coll Cardiol 1999;34:1689-95.
27. Rogers WJ, Bowlby LJ, Chandra NC, et al. Treatment of myocardial infarction in the United States (1990 to 1993); observations from the National Registry of Myocardial Infarction. Circulation 1994;9:2103-14.
28. Chen J, Marciniak TA, Radford MJ, Wang Y, Krumholz HM. Beta blocker therapy for secondary prevention of myocardial infarction in elderly diabetic patients. Results from the National Cooperative Cardiovascular Project. J Am Coll Cardiol 1999;34:1388-94.
29. Krumholz HM, Chen J, Chen YT, Wang Y, Radford MJ. Predicting one-year mortality among elderly survivors of hospitalization for an acute myocardial infarction: Results from the Cooperative Cardiovascular Project. J Am Coll Cardiol 2001;38:453-9.
30. Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 1998;339:489-97.
31. Tolbert TG, Geraci SA, Peacher-Ryan H, Winber SL. Factors predicting the failure to prescribe beta blockers in geriatric post myocardial infarction patients. Chest 1998;114:269S.